Schroeder Mark S
SEC CIK 1793112 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| LH | Labcorp | EVP, Pres-Diagnostics Lab | 11.2K | — | $6.98M | 57 | 2021-11-05 | 2026-03-26 |
Most active insiders at LH, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Schechter Adam H | Pres, CEO, Dir | — | $8.44M |
| 2 | Parham Richelle P | Dir | — | $1.78M |
| 3 | Wilkinson Peter J | SVP, CAO | — | $1.06M |
| 4 | ANDERSON KERRII B | Dir | — | $954.1K |
| 5 | Caveney Brian J | EVP, CMO, CSO, Pres of ED | — | $429.5K |
| 6 | Meltzer Jonathan C | EVP, Ops | — | $298.8K |
| 7 | Summy Amy B. | EVP, CMO | — | $283.4K |
| 8 | Kyle Kathryn W | EVP, CLO | — | $227.4K |
| 9 | van der Vaart Sandra D | EVP, Corp. Affairs | — | $156.0K |
| 10 | Vaughn Bryan T | EVP, Pres, Diagnostics | — | $67.0K |
| 15 | Schroeder Mark S | EVP, COO, Pres Diagnostics | — | — |
Transactions 57
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-03-30 | 2026-03-26 | LH | Labcorp | Schroeder Mark S | EVP, COO, Pres Diagnostics | F - Tax | $268.38 | -6,068 | 11.2K | -35% | -$1.63M |
| M | 2026-03-30 | 2026-03-26 | LH | Labcorp | Schroeder Mark S | EVP, COO, Pres Diagnostics | A - Grant | $0.00 | +12.3K | 15.8K | +350% | $0 |
| D | 2026-02-13 | 2026-02-11 | LH | Labcorp | Schroeder Mark S | EVP, COO, Pres Diagnostics | M - OptEx | — | +806 | 6,732 | +14% | — |
| D | 2026-02-13 | 2026-02-11 | LH | Labcorp | Schroeder Mark S | EVP, COO, Pres Diagnostics | F - Tax | $289.89 | -259 | 6,473 | -4% | -$75.1K |
| DM | 2026-02-10 | 2026-02-06+ | LH | Labcorp | Schroeder Mark S | EVP, COO, Pres Diagnostics | M - OptEx | — | +1,424 | 6,145 | +30% | — |
| DM | 2026-02-10 | 2026-02-06+ | LH | Labcorp | Schroeder Mark S | EVP, COO, Pres Diagnostics | F - Tax | $275.67 | -458 | 5,926 | -7% | -$126.3K |
| 2025-03-31 | 2025-03-28 | LH | Labcorp | Schroeder Mark S | EVP, COO, Pres Diagnostics | S - Sale | $231.67 | -2,635 | 4,960 | -35% | -$610.5K | |
| 2025-03-31 | 2025-03-27 | LH | Labcorp | Schroeder Mark S | EVP, COO, Pres Diagnostics | A - Grant | $0.00 | +4,840 | 9,800 | +98% | $0 | |
| 2025-03-31 | 2025-03-27 | LH | Labcorp | Schroeder Mark S | EVP, COO, Pres Diagnostics | F - Tax | $231.67 | -2,205 | 7,595 | -22% | -$510.8K | |
| D | 2025-03-04 | 2025-02-28 | LH | Labcorp | Schroeder Mark S | EVP, COO, Pres Diagnostics | S - Sale+OE | $249.23 | -5,339 | 4,960 | -52% | -$1.33M |
| D | 2025-03-04 | 2025-02-28 | LH | Labcorp | Schroeder Mark S | EVP, COO, Pres Diagnostics | M - OptEx | $131.43 | +3,903 | 10.3K | +61% | +$513.0K |
| D | 2025-02-13 | 2025-02-11 | LH | Labcorp | Schroeder Mark S | EVP, COO, Pres Diagnostics | F - Tax | $245.14 | -134 | 6,396 | -2% | -$32.8K |
| D | 2025-02-13 | 2025-02-11 | LH | Labcorp | Schroeder Mark S | EVP, COO, Pres Diagnostics | M - OptEx | — | +473 | 6,530 | +8% | — |
| DM | 2025-02-10 | 2025-02-06+ | LH | Labcorp | Schroeder Mark S | EVP, COO, Pres Diagnostics | F - Tax | $247.04 | -403 | 6,057 | -6% | -$99.6K |
| DM | 2025-02-10 | 2025-02-06+ | LH | Labcorp | Schroeder Mark S | EVP, COO, Pres Diagnostics | M - OptEx | — | +1,424 | 5,779 | +33% | — |
| 2024-04-03 | 2024-04-01 | LH | Labcorp | Schroeder Mark S | EVP, COO, Pres Diagnostics | S - Sale | $217.29 | -6,477 | 5,036 | -56% | -$1.41M | |
| D | 2024-03-29 | 2024-03-27 | LH | Labcorp | Schroeder Mark S | EVP, COO, Pres Diagnostics | F - Tax | $216.57 | -5,079 | 11.5K | -31% | -$1.10M |
| D | 2024-03-29 | 2024-03-27 | LH | Labcorp | Schroeder Mark S | EVP, COO, Pres Diagnostics | M - OptEx | — | +11.6K | 16.6K | +229% | — |
| D | 2024-03-11 | 2024-03-07 | LH | Labcorp | Schroeder Mark S | EVP, COO, Pres Diagnostics | S - Sale+OE | $218.45 | -5,048 | 5,036 | -50% | -$1.10M |
| D | 2024-03-11 | 2024-03-07 | LH | Labcorp | Schroeder Mark S | EVP, COO, Pres Diagnostics | M - OptEx | $117.09 | +2,119 | 10.1K | +27% | +$248.1K |
| D | 2024-02-13 | 2024-02-11 | LH | Labcorp | Schroeder Mark S | EVP, COO, Pres Diagnostics | M - OptEx | — | +472 | 8,091 | +6% | — |
| D | 2024-02-13 | 2024-02-12 | LH | Labcorp | Schroeder Mark S | EVP, COO, Pres Diagnostics | F - Tax | $227.45 | -126 | 7,965 | -2% | -$28.7K |
| DM | 2024-02-08 | 2024-02-07 | LH | Labcorp | Schroeder Mark S | EVP, COO, Pres Diagnostics | M - OptEx | — | +680 | 7,663 | +10% | — |
| DM | 2024-02-08 | 2024-02-07 | LH | Labcorp | Schroeder Mark S | EVP, COO, Pres Diagnostics | F - Tax | $223.71 | -182 | 7,500 | -2% | -$40.7K |
| D | 2024-02-06 | 2024-02-02 | LH | Labcorp | Schroeder Mark S | EVP, COO, Pres Diagnostics | F - Tax | $221.54 | -132 | 7,121 | -2% | -$29.2K |
| D | 2024-02-06 | 2024-02-02 | LH | Labcorp | Schroeder Mark S | EVP, COO, Pres Diagnostics | M - OptEx | — | +495 | 7,253 | +7% | — |
| D | 2023-05-22 | 2023-05-18 | LH | Labcorp | Schroeder Mark S | EVP, COO, Pres Diagnostics | S - Sale+OE | $216.77 | -1,500 | 6,687 | -18% | -$325.2K |
| D | 2023-05-22 | 2023-05-18 | LH | Labcorp | Schroeder Mark S | EVP, COO, Pres Diagnostics | M - OptEx | $130.60 | +1,500 | 8,187 | +22% | +$195.9K |
| 2023-04-03 | 2023-03-31 | LH | Labcorp | Schroeder Mark S | EVP, Pres-Diagnostics Lab | S - Sale | $225.81 | -3,897 | 6,687 | -37% | -$880.0K | |
| 2023-04-03 | 2023-03-30 | LH | Labcorp | Schroeder Mark S | EVP, Pres-Diagnostics Lab | A - Grant | $0.00 | +6,763 | 13.5K | +101% | $0 | |
| 2023-04-03 | 2023-03-30 | LH | Labcorp | Schroeder Mark S | EVP, Pres-Diagnostics Lab | F - Tax | $224.70 | -2,866 | 10.6K | -21% | -$644.0K | |
| 2023-02-16 | 2023-02-14 | LH | Labcorp | Schroeder Mark S | EVP, Pres-Diagnostics Lab | S - Sale | $247.63 | -309 | 6,687 | -4% | -$76.5K | |
| D | 2023-02-14 | 2023-02-11 | LH | Labcorp | Schroeder Mark S | EVP, Pres-Diagnostics Lab | M - OptEx | — | +423 | 7,110 | +6% | — |
| D | 2023-02-14 | 2023-02-13 | LH | Labcorp | Schroeder Mark S | EVP, Pres-Diagnostics Lab | F - Tax | $248.13 | -114 | 6,996 | -2% | -$28.3K |
| D | 2023-02-09 | 2023-02-07 | LH | Labcorp | Schroeder Mark S | EVP, Pres-Diagnostics Lab | S - Sale | $243.01 | -409 | 6,687 | -6% | -$99.4K |
| D | 2023-02-07 | 2023-02-06 | LH | Labcorp | Schroeder Mark S | EVP, Pres-Diagnostics Lab | F - Tax | $244.50 | -151 | 7,096 | -2% | -$36.9K |
| D | 2023-02-07 | 2023-02-04 | LH | Labcorp | Schroeder Mark S | EVP, Pres-Diagnostics Lab | M - OptEx | — | +560 | 7,247 | +8% | — |
| D | 2023-02-06 | 2023-02-03 | LH | Labcorp | Schroeder Mark S | EVP, Pres-Diagnostics Lab | S - Sale+OE | $253.90 | -324 | 6,687 | -5% | -$82.3K |
| D | 2023-02-06 | 2023-02-02 | LH | Labcorp | Schroeder Mark S | EVP, Pres-Diagnostics Lab | F - Tax | $254.99 | -119 | 7,011 | -2% | -$30.3K |
| D | 2023-02-06 | 2023-02-02 | LH | Labcorp | Schroeder Mark S | EVP, Pres-Diagnostics Lab | M - OptEx | — | +443 | 7,130 | +7% | — |
| 2022-11-10 | 2022-11-08 | LH | Labcorp | Schroeder Mark S | EVP, Pres-Diagnostics Lab | S - Sale | $232.67 | -1,116 | 6,687 | -14% | -$259.7K | |
| D | 2022-11-08 | 2022-11-05 | LH | Labcorp | Schroeder Mark S | EVP, Pres-Diagnostics Lab | M - OptEx | — | +2,010 | 8,697 | +30% | — |
| D | 2022-11-08 | 2022-11-07 | LH | Labcorp | Schroeder Mark S | EVP, Pres-Diagnostics Lab | F - Tax | $233.77 | -894 | 7,803 | -10% | -$209.0K |
| 2022-03-31 | 2022-03-29 | LH | Labcorp | Schroeder Mark S | EVP, Pres-Diagnostics Lab | S - Sale | $277.11 | -2,356 | 6,606 | -26% | -$652.9K | |
| 2022-03-29 | 2022-03-28 | LH | Labcorp | Schroeder Mark S | EVP, Pres-Diagnostics Lab | F - Tax | $276.42 | -1,885 | 8,962 | -17% | -$521.1K | |
| 2022-03-29 | 2022-03-27 | LH | Labcorp | Schroeder Mark S | EVP, Pres-Diagnostics Lab | A - Grant | $0.00 | +4,241 | 10.8K | +64% | $0 | |
| 2022-02-17 | 2022-02-15 | LH | Labcorp | Schroeder Mark S | EVP, Pres-Diagnostics Lab | S - Sale | $273.98 | -207 | 6,606 | -3% | -$56.7K | |
| D | 2022-02-15 | 2022-02-12 | LH | Labcorp | Schroeder Mark S | EVP, Pres-Diagnostics Lab | M - OptEx | — | +284 | 6,890 | +4% | — |
| D | 2022-02-15 | 2022-02-14 | LH | Labcorp | Schroeder Mark S | EVP, Pres-Diagnostics Lab | F - Tax | $272.68 | -77 | 6,812 | -1% | -$21.0K |
| D | 2022-02-08 | 2022-02-07 | LH | Labcorp | Schroeder Mark S | EVP, Pres-Diagnostics Lab | S - Sale+OE | $277.38 | -204 | 6,606 | -3% | -$56.6K |
| D | 2022-02-08 | 2022-02-04 | LH | Labcorp | Schroeder Mark S | EVP, Pres-Diagnostics Lab | M - OptEx | — | +560 | 6,962 | +9% | — |
| D | 2022-02-08 | 2022-02-04 | LH | Labcorp | Schroeder Mark S | EVP, Pres-Diagnostics Lab | F - Tax | $277.48 | -152 | 6,810 | -2% | -$42.2K |
| D | 2022-02-04 | 2022-02-03 | LH | Labcorp | Schroeder Mark S | EVP, Pres-Diagnostics Lab | S - Sale+OE | $271.81 | -161 | 6,402 | -2% | -$43.8K |
| D | 2022-02-04 | 2022-02-02 | LH | Labcorp | Schroeder Mark S | EVP, Pres-Diagnostics Lab | F - Tax | $273.18 | -121 | 6,562 | -2% | -$33.1K |
| D | 2022-02-04 | 2022-02-02 | LH | Labcorp | Schroeder Mark S | EVP, Pres-Diagnostics Lab | M - OptEx | — | +443 | 6,684 | +7% | — |
| D | 2021-11-09 | 2021-11-05 | LH | Labcorp | Schroeder Mark S | EVP, Pres-Diagnostics Lab | F - Tax | $274.84 | -899 | 6,240 | -13% | -$247.1K |
| D | 2021-11-09 | 2021-11-05 | LH | Labcorp | Schroeder Mark S | EVP, Pres-Diagnostics Lab | M - OptEx | — | +2,010 | 7,140 | +39% | — |
Purchase Sale Sale after option exercise All abbreviations